Back
Perspective Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
CATX
Sponsored
9,530x the last time this happened
Here's what our expert says you should buy before April 14.
Buy
84
CATX
Perspective Therapeutics
Last Price:
1.81
Seasonality Move:
1.64%
7 Day Trial
ALL ACCESS PASS
$
7
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.Perspective Therapeutics Price Quote
$1.81
Perspective Therapeutics Key Stats
Buy
84
Perspective Therapeutics (CATX)
is a Buy
Day range:
$1.72 - $1.87
52-week range:
$0.21 - $1.87
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
14.13%
Volume:
4.7M
Avg. volume:
5.6M
1-year change:
195.99%
Market cap:
$1.1B
Revenue:
$0
EPS:
$-0.17
How Much Does Perspective Therapeutics Make?
Data Unavailable
Is Perspective Therapeutics Growing As A Company?
Data Unavailable
Perspective Therapeutics Stock Price Performance
-
Did Perspective Therapeutics Stock Go Up Last Month?
Perspective Therapeutics share price went up by 25.69% last month -
Did CATX's Share Price Rise Over The Last Year?
CATX share price rose by 195.99% over the past 1 year
What Is Perspective Therapeutics 52-Week High & Low?
-
What Is Perspective Therapeutics’s 52-Week High Share Price?
Perspective Therapeutics has traded as high as $1.87 over the past 52 weeks -
What Is Perspective Therapeutics’s 52-Week Low Share Price?
Perspective Therapeutics has traded as low as $0.21 over the past 52 weeks
Perspective Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Perspective Therapeutics?
-
How Much Debt Does Perspective Therapeutics Have?
Total long term debt quarterly is $1.7M -
How Much Cash Does Perspective Therapeutics Have?
Cash and short term investments quarterly total is $9.2M -
What Is Perspective Therapeutics’s Book Value Per Share?
Book value per share is 0.27
Is Perspective Therapeutics Cash Flow Positive?
-
What Is CATX Cash Flow From Operations?
Cash flow from operations (TTM) is -$36.9M -
What Is Perspective Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $785K -
What Is Perspective Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $24.4M
Perspective Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
CATX return on invested capital is -49.97% -
What Is Perspective Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -44.83% -
What Is CATX Return On Equity?
ROE is a measure of profitability and is -50.74%
Perspective Therapeutics Earnings Date & Stock Price
-
What Is Perspective Therapeutics's Stock Price Today?
A single share of CATX can be purchased today for 1.81 -
What Is Perspective Therapeutics’s Stock Symbol?
Perspective Therapeutics trades on the nyam under the ticker symbol: CATX -
When Is Perspective Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Perspective Therapeutics is scheduled on May 6, 2024 -
When Is CATX's next ex-dividend date?
Perspective Therapeutics's next ex-dividend date is May 4, 2024 -
How To Buy Perspective Therapeutics Stock?
You can buy Perspective Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Perspective Therapeutics Competitors
-
Who Are Perspective Therapeutics's Competitors?
Below is a list of companies who compete with Perspective Therapeutics or are related in some way:
Perspective Therapeutics Dividend Yield
Data Unavailable
Perspective Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 0% | -331.06% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 1.57 |
Downside from Last Price: | -13.44% |